pyridinolcarbamate has been researched along with Nephrotic Syndrome in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lagrue, G | 1 |
| Branellec, A | 1 |
| Blanc, C | 1 |
| Xheneumont, S | 1 |
| Beaudoux, F | 1 |
| Sobel, A | 1 |
| Weil, B | 1 |
1 other study available for pyridinolcarbamate and Nephrotic Syndrome
| Article | Year |
|---|---|
A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties.
Topics: Blood Proteins; Capillary Permeability; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; Di | 1975 |